Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy

World Journal of Gastroenterology

Volumn 13, Issue 21, 2007, Pages 3003-3008

  Bao, Zhi Jun ^a   Qiu, De Kai ^a   Ma, Xiong ^a   Fan, Zhu Ping ^a   Zhang, Gan Sheng ^b   Huang, Yi Qin ^b   Yu, Xiao Feng ^b   Zeng, Min De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Chinese; Chronic hepatitis B; Health related quality of life; Liver cirrhosis; Minimal hepatic encephalopathy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANXIETY; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; HEPATIC ENCEPHALOPATHY; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; STATISTICAL ANALYSIS;

EID: 34447093549     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i21.3003     Document Type: Article

References (32)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
2. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75: 462-469
3. Gitlin N. Subclinical portal-systemic encephalopathy. Am J Gastroenterol 1988; 83: 8-11
4. Bayliss MS. Methods in outcomes research in hepatology: definitions and domains of quality of life. Hepatology 1999; 29: 35-65
5. Hauser W, Grandt D. Measuring quality of life in gastroenterology - concepts, instruments and problems. Z Gastroenterol 2001; 39: 475-481
6. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483
7. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45: 295-300
8. Chinese Society of Infectious Disease and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. The program of prevention and cure for viral hepatitis. Zhonghua Ganzangbing Zazhi 2000; 8: 324-329
9. Bao ZJ, Qiu DK, Ma X, Zhang GS, Gu T, Yu XF, Fan ZP, Li JQ, Zeng MD. The primary use of psychometric measures for the diagnosis of minimal hepatic encephalopathy. Zhonghua Xiaohua Zazhi 2006; 26: 606-609
10. Li YY, Nie YQ, Sha WH, Zeng Z, Yang FY, Ping L, Jia L. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-2401
11. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-2034
12. Groeneweg M, Quero JC, De Bruijn I, Hartmarm IJ, Essink-bot ML, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-49
13. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000; 32: 748-753
14. Yacavone RF, Locke GR 3rd, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol 2001; 96: 285-297
15. Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 945-952
16. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56: 395-407
17. Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840
18. Guyatt GH, Feeny DH. Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629
19. Pukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 51: 1037-1044
20. Ferrer M, Cordoba J, Garin O, Olive G, Flavia M, Vargas V, Esteban R, Alonso J. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl 2006; 12: 95-104
21. Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the Chronic Liver Disease Questionnaire. Eur J Gastroenterol Hepatol 2004; 16: 599-606
22. Rucci P, Taliani G, Cirrincione L, Alberti A, Bartolozzi D, Caporaso N, Colombo M, Coppola R, Chiaramonte M, Craxi A, De Sio I, Floreani AR, Gaeta GB, Persico M, Secchi G, Versace I, Mele A. Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis 2005; 37: 850-860
23. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 75-82
24. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis 1996; 16: 321-328
25. Yang SS, Wu CH, Chiang TR, Chen DS. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology 1998; 27: 357-361
26. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-535
27. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723
28. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39: 739-745
29. Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 13-19
30. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-559
31. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53: 758-763
32. Younossi ZM, Guyatt G. Quality-of-life assessments and chronic liver disease. Am J Gastroenterol 1998; 93: 1037-1041